Rhythm Pharmaceuticals, Inc. (RYTM)

NASDAQ: RYTM · Real-Time Price · USD

87.86

+2.15 (2.50%)

Jun 11, 2026, 2:02 PM EDT - Market open

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Product Revenue, Net	217.17M	194.77M	130.13M
Product Revenue, Net Growth	11.50%	49.68%	68.06%
License Revenue	-	-5.01M	-
Revenue (Total)	217.17M	189.76M	130.13M
Revenue (Total) Growth	14.44%	45.83%	68.06%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
License Revenue	-	-5.01M	-
United States Revenue	146.08M	133.55M	96.11M
United States Revenue Growth	9.38%	38.96%	53.96%
International Revenue	-	-	34.02M
International Revenue Growth	-	-	126.74%
Revenue (Other)	71.09M	61.22M	-
Revenue (Total)	217.17M	189.76M	130.13M
Revenue (Total) Growth	14.44%	45.83%	68.06%

Updated May 5, 2026. Data Source: Fiscal.ai.